ATE169740T1 - Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung - Google Patents

Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung

Info

Publication number
ATE169740T1
ATE169740T1 AT96401041T AT96401041T ATE169740T1 AT E169740 T1 ATE169740 T1 AT E169740T1 AT 96401041 T AT96401041 T AT 96401041T AT 96401041 T AT96401041 T AT 96401041T AT E169740 T1 ATE169740 T1 AT E169740T1
Authority
AT
Austria
Prior art keywords
immunoassays
preparation
production
stabilized troponin
troponin
Prior art date
Application number
AT96401041T
Other languages
English (en)
Inventor
Denis Robert Marie Riochet
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Application granted granted Critical
Publication of ATE169740T1 publication Critical patent/ATE169740T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716Muscle proteins, e.g. myosin, actin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4712Muscle proteins, e.g. myosin, actin, protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96401041T 1995-05-16 1996-05-13 Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung ATE169740T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505788A FR2734267B1 (fr) 1995-05-16 1995-05-16 Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee

Publications (1)

Publication Number Publication Date
ATE169740T1 true ATE169740T1 (de) 1998-08-15

Family

ID=9479025

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96401041T ATE169740T1 (de) 1995-05-16 1996-05-13 Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung

Country Status (9)

Country Link
US (2) US20010006683A1 (de)
EP (1) EP0743522B1 (de)
JP (1) JP3672672B2 (de)
AT (1) ATE169740T1 (de)
CA (1) CA2176655C (de)
DE (1) DE69600512T2 (de)
DK (1) DK0743522T3 (de)
ES (1) ES2122768T3 (de)
FR (1) FR2734267B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3178697A (en) * 1996-06-25 1998-01-14 Oy Aboatech Ab Method and kit for the diagnosis of troponin i
US7285418B2 (en) 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
DE19647927A1 (de) * 1996-11-20 1998-05-28 Bayer Ag Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
JP2002508839A (ja) * 1997-05-29 2002-03-19 メディカル アナリシス システムズ,インコーポレイテッド 共有結合したトロポニン複合体
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
EP1000140A1 (de) * 1997-06-13 2000-05-17 Medical Analysis Systems, Inc. (MAS) Stabilisierte herz-marker-zusammensetzungen
ATE463509T1 (de) * 2005-04-28 2010-04-15 Abbott Lab Stabilisierung von herz-troponin
EP2679997B1 (de) * 2011-02-25 2020-05-20 LSI Medience Corporation Verfahren zur Messung von kardialem Troponin
JP5759211B2 (ja) * 2011-03-11 2015-08-05 三洋化成工業株式会社 凍結乾燥方法
CN113125745B (zh) * 2019-12-31 2022-10-28 瑞博奥(广州)生物科技股份有限公司 一种心脏功能检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
CA2162121A1 (en) * 1993-05-17 1994-11-24 Richard W. Wicks Assay for cardiac troponin i
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays

Also Published As

Publication number Publication date
US20040033529A1 (en) 2004-02-19
US20010006683A1 (en) 2001-07-05
ES2122768T3 (es) 1998-12-16
CA2176655A1 (en) 1996-11-17
JP3672672B2 (ja) 2005-07-20
DE69600512T2 (de) 1999-04-15
JPH0921804A (ja) 1997-01-21
CA2176655C (en) 2002-01-29
DK0743522T3 (da) 1999-05-10
FR2734267B1 (fr) 1997-08-01
FR2734267A1 (fr) 1996-11-22
EP0743522A1 (de) 1996-11-20
EP0743522B1 (de) 1998-08-12
DE69600512D1 (de) 1998-09-17

Similar Documents

Publication Publication Date Title
AT384805B (de) Verfahren zur herstellung von neuen 1,2-diaminocyclobuten-3,4-dionen und deren salzen
ATE169740T1 (de) Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung
ATA122485A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
AT383606B (de) Verfahren zur herstellung von neuen transparenten copolyamiden mischungen daraus, und deren verwendung zur herstellung von formkoerpern
DE3688209D1 (de) Verfahren zur herstellung von kohlenstoffilamenten und durch dieses verfahren erhaltene kohlenstoffilamente.
DE3867684D1 (de) Kupferoxid-supraleiter mit gemischter wertigkeit und verfahren zu seiner herstellung.
DE69526863D1 (de) Neue 1,2-dioxetane mit haloalkoxy-gruppen, verfahren zur herstellung und verwendung
ATE47138T1 (de) Verfahren zur herstellung von 1,2-dithiolan-3pentans|ure (thioctsaeure).
DE3678071D1 (de) Verfahren zur herstellung von polyvinylidenfluoridpfropfcopolymeren und membranen aus polyvinylidenfluoridpolymeren mit diesem verfahren erhalten.
DE58909866D1 (de) Kontinuierliches Verfahren zur Herstellung von resorbierbaren Polyestern und deren Verwendung
ATE148110T1 (de) Verfahren zur herstellung von metallkomplexen der n-beta-hydroxy-alkyl-tri-n-carboxyalkyl-1,4,7,1 - tetraazacyclododecan- und n-beta-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11 tetraazacyclotetradecan- derivate
DE3885501D1 (de) Butadien-Styrol-Blockcopolymere mit unsymmetrischem Aufbau und deren Herstellung und Verwendung als Formmassen.
ATE131149T1 (de) Verfahren zur herstellung von 5-(2,4- difluorphenyl)-salizylsäure.
DE3671246D1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.
AT388738B (de) Verfahren zur herstellung von wasserverduennbaren lackbindemitteln und deren verwendung
AT381494B (de) Verfahren zur herstellung neuer 2,3,4-trinor-1,5inter-m-phenylen-prostacyclin-derivaten und von deren salzen
ATE80388T1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
DE68903570D1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
DE3785537D1 (de) Mikroorganismus und verfahren zur herstellung von oxydationsverbindungen mit diesem mikroorganismus.
DE3670093D1 (de) Mischungen aus polyphenylenether und polyamid und deren verwendung zur herstellung thermoplastischer formmassen.
DE3787765D1 (de) Antibiotika "Mureidomycine A,B,C und D" genannt, deren Verfahren zur Herstellung und deren Verwendung.
AT388382B (de) Verfahren zur herstellung von wasserverduennbaren lackbindemitteln und deren verwendung
AT379393B (de) Verfahren zur herstellung neuer 6-hydrazono-pyrido(2,1-b)chinazolin-11-on-deriv te, von deren salzen sowie von deren stereomeren
DE3887019D1 (de) Verfahren zur herstellung von zusammensetzungen mit anti-magengeschwür-wirkung.
ATE127127T1 (de) Verfahren zur herstellung einer intramolekularen disulphid-brücke in polypeptiden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EEFA Change of the company name